HCA Healthcare (HCA) fundamentals: P/E, valuation, undervalued?
HCA Healthcare · Health Care · ref. ETF XLV · price $419.34
In short — HCA Healthcare trades at 14.1× earnings (P/E), 13.1× forward, with a net margin of 8.8 % and revenue growth of +9 %. Read: Fairly valued (P/E 13 in line with ~12% growth (PEG 1.1)).
Is HCA Healthcare stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$419.34+3.0% over range
Aug 28, 25low $361.32 · high $545.13Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
63% recommend buying · 16 analysts
Valuation : Fairly valued — P/E 13 in line with ~12% growth (PEG 1.1)
Valuation
14.1
P/E (price/earnings)
13.1
Forward P/E
1.21
PEG
—
Price/book (P/B)
$90.8B
Market cap
29.82
EPS
Profitability & growth
8.8 %
Net margin
+9 %
Revenue growth
+12 %
Earnings growth
$51.6B
Total debt
HCA Healthcare income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $60.2B | $5.6B | 9.4 % |
| 2023 | $65.0B | $5.2B | 8.1 % |
| 2024 | $70.6B | $5.8B | 8.2 % |
| 2025 | $75.6B | $6.8B | 9.0 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is HCA Healthcare's P/E and is the stock undervalued? What's a good P/E?
HCA Healthcare's P/E is 14.1 (forward 13.1). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Fairly valued".
Is HCA Healthcare profitable?
HCA Healthcare has a net margin of 8.8 % (EPS 29.82). The company is profitable.
Is HCA stock expensive?
Our read: "Fairly valued" — P/E 13 in line with ~12% growth (PEG 1.1). Cross-check with growth and sector.
💬 A question about HCA Healthcare? The JPI assistant answers using our backtest data.